Reshma Rangwala
EVP & Chief Medical Officer · 2 filings · Latest: May 13, 2026
Karyopharm Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
KPTI | Reshma Rangwala | EVP & Chief Medical Officer | May 14, 2026 | Sale | $9.50 | 408 | $3.9K | 56,829 | |
KPTI | Reshma Rangwala | EVP & Chief Medical Officer | May 13, 2026 | Grant/Award | $0.00 | 947 | — | 57,237 | |
KPTI | Reshma Rangwala | EVP & Chief Medical Officer | Apr 21, 2026 | Sale | $8.94 | 449 | $4.0K | 56,290 |